Search for Clinical Trial Results

Sponsored By

Genetic Diseases, X-Linked - 25 Studies Found

Status Study
Completed Study Name: Genetic Studies of X-linked Lymphoproliferative Disease
Condition:
  • X-Linked Lymphoproliferative Disease
  • Lymphoproliferative Disease
  • Retinitis Pigmentosa
  • X-linked Genetic Diseases

Date: 2004-12-27
Interventions: Drug: docosahexaenoic acid OR corn/soy oil placebo daily intake of DHA based on body weight or corn/soy
Not yet recruiting Study Name: Therapeutic Use of Tadekinig Alfa in NLRC4 Mutation and XIAP Deficiency
Condition:
  • NLRC4-MAS
  • XIAP Deficiency

Date: 2017-02-28
Interventions:
  • Drug: Tadekinig alfa Tadekinig
Completed Study Name: Bipolar Research Study Using MR Imaging
Condition: Bipolar Affective Disorder
Date: 2014-03-07
Interventions: Other: MRI scanning
Completed Study Name: Bipolar Intervention Study: Cognitive Interpersonal Therapy
Condition:
  • Mania
  • Hypomania
  • Bipolar Affective Disorder

Date: 2011-03-07
Interventions:
  • Other: Cognitive Interpersonal Therapy

Enrolling by invitation Study Name: Phase 3 Extension Study of Ataluren (PTC124) in Patients With Nonsense Mutation Dystrophinopathy
Condition:
  • Muscular Dystrophy, Duchenne
  • Muscular Dystrophies
  • Muscular
    Date: 2014-03-17
    Interventions: Drug: Ataluren Other Name: PTC124
Completed Study Name: Phase 3 Study of Ataluren in Patients With Nonsense Mutation Duchenne Muscular Dystrophy
Condition:
  • Muscular Dystrophy, Duchenne
  • Muscular Dystrophies
  • Muscular
    Date: 2013-03-26
    Interventions:
    • Drug: Ataluren Ataluren PO 10-
Recruiting Study Name: Assessment of Immunogenicity of Zostavax® in Patients With Antibody Deficiency 60 Years of Age and Older
Condition:
  • Common Variable Immune Deficiency
  • Specific Antibody Deficiency
  • Wiskott-Aldrich Syndrome (WAS)
  • X-linked Thrombocytopenia

Date: 2008-10-16
Interventions: Drug: Interleukin-2 We propose to subcutaneously administer 0.5 MU/m2 of IL-2 daily to WAS subjects for
Next >>>